Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 13 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 9 Leukemia 8 Leukemia, Myeloid, Chronic-Phase 7 Burkitt Lymphoma 6 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4 Prostatic Neoplasms 3 Multiple Myeloma 3 Lymphoma 3 Philadelphia Chromosome 2 Pancreatic Neoplasms 2 Neoplasms 2 Leukemia, Myeloid, Acute 2 Leukemia, Biphenotypic, Acute 2 Hematologic Neoplasms 2 Glioma 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Recurrence 1 Rectal Neoplasms 1 Prostate Cancer Recurrent 1 Primary Myelofibrosis 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Ovarian Neoplasms 1 Neuroblastoma 1 Neoplasm, Residual 1

Interventions

Cyclophosphamide 28 Temozolomide 25 Irinotecan 21 dinutuximab 20 Topotecan 15 Magnetic Resonance Spectroscopy 13 Specimen Handling 12 Biopsy 12 naxitamab 11 Granulocyte-Macrophage Colony-Stimulating Factor 11 3-Iodobenzylguanidine 11 Vincristine 10 Etoposide 10 sargramostim 9 Melphalan 9 Isotretinoin 9 fludarabine 8 X-Rays 8 Colony-Stimulating Factors 8 Carboplatin 8 etoposide phosphate 7 Phantoms, Imaging 7 Doxorubicin 7 fludarabine phosphate 6 Stem Cell Transplantation 6 Nuclear Medicine Department, Hospital 6 Eflornithine 6 Thiotepa 5 Granulocyte Colony-Stimulating Factor 5 Filgrastim 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neuroblastoma × Dasatinib × 1 year × Clear all

NCT02559778 2026-04-28

PEDS-PLAN

Milton S. Hershey Medical Center

Phase 2 Recruiting

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡